Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo

NCT07172347 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-segmental Vitiligo

Interventions

DRUG: VC005 tablets
DRUG: VC005 Tablets Placebo

Sponsor

Jiangsu vcare pharmaceutical technology co., LTD